STOCKHOLM, SWEDEN - BTS Group AB (publ), - BTS, a leading global strategy implementation firm, invites the media and analysts to attend the presentation of the Q3 2016 interim report with CEO Henrik Ekelund.
Date: Friday November 18th at 9.30am CET
Address: Malmskillnadsgatan 29 in Stockholm, ground floor
Venue: Brunkeberg
The report will be published at 8:00am the same day.
You are welcome to participate in person, via an audiocast or through a conference call. All options offer the opportunity to ask questions. The presentation will be in English.
Audiocast:
Please use the following link;
https://wonderland.videosync.fi/bts-group-q3-report
Conference call:
Please call any of the following numbers:
Sweden +46 856642692
UK +44 02030089801
US +18558315944
The interim report, the presentation and the audiocast will be available afterwards on http://ir.bts.com/index.cfm.
For more information, please contact:
Michael Wallin
Head of investor relations
BTS Group AB
E-mail: [email protected]
Mobile: +46 708-788 019
About BTS Group AB
BTS is a global professional services firm headquartered in Stockholm, Sweden, with some 500 professionals in 34 offices located on six continents. We focus on the people side of strategy, working with leaders at all levels to help them make better decisions, convert those decisions to actions and deliver results. At our core, we believe people learn best by doing. For 30 years, we've been designing fun, powerful experiences that have a profound and lasting impact on people and their careers. We inspire new ways of thinking, build critical capabilities and unleash business success. It's strategy made personal.
We serve a wide range of client needs, including:
• Assessment centers for talent selection and development
• Strategy alignment and execution
• Business acumen, leadership and sales training programs
• On-the-job business simulations and application tools.
We partner with nearly 450 organizations, including over 30 of the world's 100 largest global corporations. Our major clients are some of the most respected names in business: AT&T, Chevron, Coca-Cola, Ericsson, Google, GSK, HP, HSBC, Salesforce.com and Unilever.
BTS is a public company listed on the Nasdaq Stockholm and trades under the symbol BTS B.
For more information, please visit www.bts.com
Every care has been taken in the translation of this press release. In the event of discrepancies, however, the Swedish original will supersede the English translation.
This information is information that BTS Group AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 09.00 CET on November 3, 2016.
Attachments:http://www.globenewswire.com/NewsRoom/AttachmentNg/610b66f7-4827-4cb1-8ea4-3a7d455cb1be


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 



